Trever G. Bivona, Ph.D. - Publications

Affiliations: 
2004 New York University, New York, NY, United States 
Area:
Cell Biology, Molecular Biology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Premasekharan G, Gilbert E, Okimoto RA, Hamirani A, Lindquist KJ, Ngo VT, Roy R, Hough J, Edwards M, Paz R, Foye A, Sood R, Copren KA, Gubens M, Small EJ, ... Bivona TG, et al. An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer. Cancer Letters. PMID 27343980 DOI: 10.1016/j.canlet.2016.06.017  0.92
2016 Bivona TG, Doebele RC. A framework for understanding and targeting residual disease in oncogene-driven solid cancers. Nature Medicine. 22: 472-8. PMID 27149220 DOI: 10.1038/nm.4091  0.92
2016 Hrustanovic G, Bivona TG. RAS signaling in ALK fusion lung cancer. Small Gtpases. 7: 32-3. PMID 26901483 DOI: 10.1080/21541248.2015.1131803  0.92
2016 Okimoto RA, Bivona TG. Tracking Down Response and Resistance to TRK Inhibitors. Cancer Discovery. 6: 14-6. PMID 26747892 DOI: 10.1158/2159-8290.CD-15-1352  0.92
2016 Pazarentzos E, Giannikopoulos P, Hrustanovic G, St John J, Olivas VR, Gubens MA, Balassanian R, Weissman J, Polkinghorn W, Bivona TG. Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3CβD1067V kinase domain mutation Oncogene. 35: 1198-1205. DOI: 10.1038/onc.2015.173  0.92
2015 Hrustanovic G, Bivona TG. RAS-MAPK in ALK targeted therapy resistance. Cell Cycle (Georgetown, Tex.). 14: 3661-2. PMID 26654768 DOI: 10.1080/15384101.2015.1096103  0.92
2015 Zill OA, Greene C, Sebisanovic D, Siew L, Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, Van Loon K, Ko AH, Tempero MA, Bivona TG, Munster PN, et al. Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. Cancer Discovery. PMID 26109333 DOI: 10.1158/2159-8290.CD-15-0274  0.92
2015 Flaherty KT, Wargo JA, Bivona TG. YAP in MAPK pathway targeted therapy resistance. Cell Cycle (Georgetown, Tex.). 14: 1765-6. PMID 26036142 DOI: 10.1080/15384101.2015.1032644  0.92
2015 Elkabets M, Pazarentzos E, Juric D, Sheng Q, Pelossof RA, Brook S, Benzaken AO, Rodon J, Morse N, Yan JJ, Liu M, Das R, Chen Y, Tam A, Wang H, ... ... Bivona TG, et al. AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas. Cancer Cell. 27: 533-46. PMID 25873175 DOI: 10.1016/j.ccell.2015.03.010  0.92
2015 Blakely CM, Pazarentzos E, Olivas V, Asthana S, Yan JJ, Tan I, Hrustanovic G, Chan E, Lin L, Neel DS, Newton W, Bobb KL, Fouts TR, Meshulam J, Gubens MA, ... ... Bivona TG, et al. NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer. Cell Reports. 11: 98-110. PMID 25843712 DOI: 10.1016/j.celrep.2015.03.012  0.92
2015 Choi YJ, Kim SY, So KS, Baek IJ, Kim WS, Choi SH, Lee JC, Bivona TG, Rho JK, Choi CM. AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells. Plos One. 10: e0119832. PMID 25780909 DOI: 10.1371/journal.pone.0119832  0.92
2015 Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E, Asthana S, Neel D, Yan JJ, Lu X, Pham L, Wang MM, Karachaliou N, Cao MG, Manzano JL, ... ... Bivona TG, et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nature Genetics. 47: 250-6. PMID 25665005 DOI: 10.1038/ng.3218  0.92
2015 Okimoto RA, Bivona TG. AXL receptor tyrosine kinase as a therapeutic target in NSCLC Lung Cancer: Targets and Therapy. 6: 27-34. DOI: 10.2147/LCTT.S60438  0.92
2015 Pazarentzos E, Bivona TG. Adaptive stress signaling in targeted cancer therapy resistance Oncogene. 34: 5599-5606. DOI: 10.1038/onc.2015.26  0.92
2015 Hrustanovic G, Olivas V, Pazarentzos E, Tulpule A, Asthana S, Blakely CM, Okimoto RA, Lin L, Neel DS, Sabnis A, Flanagan J, Chan E, Varella-Garcia M, Aisner DL, Vaishnavi A, ... ... Bivona TG, et al. RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer Nature Medicine. DOI: 10.1038/nm.3930  0.92
2014 Okimoto RA, Bivona TG. Recent advances in personalized lung cancer medicine. Personalized Medicine. 11: 309-321. PMID 25506379 DOI: 10.2217/pme.14.19  0.92
2014 Molina-Vila MA, Nabau-Moretó N, Tornador C, Sabnis AJ, Rosell R, Estivill X, Bivona TG, Marino-Buslje C. Activating mutations cluster in the "molecular brake" regions of protein kinases and do not associate with conserved or catalytic residues. Human Mutation. 35: 318-28. PMID 24323975 DOI: 10.1002/humu.22493  0.92
2013 Rosell R, Bivona TG, Karachaliou N. Genetics and biomarkers in personalisation of lung cancer treatment. Lancet (London, England). 382: 720-31. PMID 23972815 DOI: 10.1016/S0140-6736(13)61715-8  0.92
2013 Sabnis AJ, Bivona TG. FGFR fusions in the driver's seat. Cancer Discovery. 3: 607-9. PMID 23749526 DOI: 10.1158/2159-8290.CD-13-0185  0.92
2013 Hrustanovic G, Lee BJ, Bivona TG. Mechanisms of resistance to EGFR targeted therapies. Cancer Biology & Therapy. 14: 304-14. PMID 23358468 DOI: 10.4161/cbt.23627  0.92
2013 Neel DS, Bivona TG. Secrets of drug resistance in NSCLC exposed by new molecular definition of EMT. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3-5. PMID 23172883 DOI: 10.1158/1078-0432.CCR-12-3232  0.92
2012 Blakely CM, Bivona TG. Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistance. Cancer Discovery. 2: 872-5. PMID 23071030 DOI: 10.1158/2159-8290.CD-12-0387  0.92
2012 Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, ... ... Bivona TG, et al. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nature Genetics. 44: 852-60. PMID 22751098 DOI: 10.1038/ng.2330  0.92
2011 Morris LG, Taylor BS, Bivona TG, Gong Y, Eng S, Brennan CW, Kaufman A, Kastenhuber ER, Banuchi VE, Singh B, Heguy A, Viale A, Mellinghoff IK, Huse J, Ganly I, et al. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers. Proceedings of the National Academy of Sciences of the United States of America. 108: 19024-9. PMID 22065749 DOI: 10.1073/pnas.1111963108  0.92
2011 Bivona TG, Hieronymus H, Parker J, Chang K, Taron M, Rosell R, Moonsamy P, Dahlman K, Miller VA, Costa C, Hannon G, Sawyers CL. FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. Nature. 471: 523-6. PMID 21430781 DOI: 10.1038/nature09870  0.92
2011 Rosell R, Molina MA, Costa C, Simonetti S, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Moran T, Mendez P, Cardenal F, Isla D, Provencio M, Cobo M, Insa A, Garcia-Campelo R, ... ... Bivona TG, et al. Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1160-8. PMID 21233402 DOI: 10.1158/1078-0432.CCR-10-2158  0.92
2008 Quatela SE, Sung PJ, Ahearn IM, Bivona TG, Philips MR. Analysis of K-Ras phosphorylation, translocation, and induction of apoptosis. Methods in Enzymology. 439: 87-102. PMID 18374158 DOI: 10.1016/S0076-6879(07)00407-7  0.92
2006 Bivona TG, Quatela S, Philips MR. Analysis of Ras activation in living cells with GFP-RBD. Methods in Enzymology. 407: 128-43. PMID 16757320 DOI: 10.1016/S0076-6879(05)07012-6  0.92
2006 Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, Miura J, Wiener HH, Wright L, Saba SG, Yim D, Fein A, Pérez de Castro I, Li C, Thompson CB, et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Molecular Cell. 21: 481-93. PMID 16483930 DOI: 10.1016/j.molcel.2006.01.012  0.92
2005 Bivona TG, Philips MR. Analysis of Ras and Rap activation in living cells using fluorescent Ras binding domains. Methods (San Diego, Calif.). 37: 138-45. PMID 16289969 DOI: 10.1016/j.ymeth.2005.05.022  0.92
2005 Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA, Iyengar R. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. The Journal of Biological Chemistry. 280: 11413-21. PMID 15657046 DOI: 10.1074/jbc.M411521200  0.92
2004 Perez de Castro I, Bivona TG, Philips MR, Pellicer A. Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Molecular and Cellular Biology. 24: 3485-96. PMID 15060167 DOI: 10.1128/MCB.24.8.3485-3496.2004  0.92
2004 Walker SA, Kupzig S, Bouyoucef D, Davies LC, Tsuboi T, Bivona TG, Cozier GE, Lockyer PJ, Buckler A, Rutter GA, Allen MJ, Philips MR, Cullen PJ. Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca2+ oscillations. The Embo Journal. 23: 1749-60. PMID 15057271 DOI: 10.1038/sj.emboj.7600197  0.92
2004 Dustin ML, Bivona TG, Philips MR. Membranes as messengers in T cell adhesion signaling. Nature Immunology. 5: 363-72. PMID 15052266 DOI: 10.1038/ni1057  0.92
2004 Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Molecular Cell. 13: 341-55. PMID 14967142 DOI: 10.1016/S1097-2765(04)00050-4  0.92
2004 Bivona TG, Wiener HH, Ahearn IM, Silletti J, Chiu VK, Philips MR. Rap1 up-regulation and activation on plasma membrane regulates T cell adhesion. The Journal of Cell Biology. 164: 461-70. PMID 14757755 DOI: 10.1083/jcb.200311093  0.92
2003 Mohney RP, Das M, Bivona TG, Hanes R, Adams AG, Philips MR, O'Bryan JP. Intersectin activates Ras but stimulates transcription through an independent pathway involving JNK. The Journal of Biological Chemistry. 278: 47038-45. PMID 12970366 DOI: 10.1074/jbc.M303895200  0.92
2003 Bivona TG, Pérez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ, Cullen PJ, Pellicer A, Cox AD, Philips MR. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature. 424: 694-8. PMID 12845332 DOI: 10.1038/nature01806  0.92
2003 Bivona TG, Philips MR. Ras pathway signaling on endomembranes. Current Opinion in Cell Biology. 15: 136-42. PMID 12648668 DOI: 10.1016/S0955-0674(03)00016-4  0.92
Show low-probability matches.